---
figid: PMC8414998__fncel-15-716947-g002
figtitle: 'Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest
  for Striking the Right Balance'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC8414998
filename: fncel-15-716947-g002.jpg
figlink: /pmc/articles/PMC8414998/figure/F2/
number: F2
caption: Astrocyte and Microglial Polarization. (A) Microglial Polarization. Microglial
  M1 polarization is thought to be driven predominantly by signal transducer and activator
  of transcription (STAT) 1/3/5 signaling and interferon regulatory factors 5 (IRF-5)
  and 8 (IRF-8) (; ). These M1-activated cells produce pro-inflammatory cytokines
  (e.g., TNF-α, IL-1β, IL-6, IFNy, and IL-23) and are characterized by increased antigen
  presenting activity secondary to increased expression of MHC-II and co-stimulatory
  (CD80 and CD86) molecules (; ). Conversely, M2 polarization depends on STAT3/6 signaling,
  peroxisome proliferator-activated receptor gamma (PPARγ)-mediated nuclear factor
  kappa B (NF-kβ) suppression, CREB-C/EBPβ and interferon regulatory factor 4 (IRF4)
  (). Cells exhibiting this phenotype promote tissue repair through the suppression
  of neurotoxic inflammation as well as through stimulating angiogenesis and tissue
  remodeling (). (B) Astrocyte Polarization. Signaling pathways implicated in regulating
  astroglial activation and determining phenotype, include the NF-kβ, sphingosine
  1-phosphate (S1P) receptor, JAK/STAT and type 1 interferon (IFN-I) pathways ().
  Several factors promote activation of NF-kβ signaling in reactive astrocytes, including
  glycolipid lactosylceramide (LacCer), type I interferons, TGF-α and VEGF-β (). Activation
  of NF-kβ by these factors stimulates astrocytes to adopt a pro-inflammatory (A1)
  (). Similarly, estrogen signaling through estrogen receptor alpha (ERα) suppresses
  NF-kβ signaling and inhibits astrocytes from adopting a pro-inflammatory phenotype
  (; ). Astrocytic IFNy signaling also acts to suppress CNS inflammation through negative
  regulation of NF-kβ (). Activation of the IFNy pathway upregulates astrocyte expression
  of the aryl hydrocarbon receptor (AhR), which suppresses inflammation via suppressor
  of cytokine signaling 2 (SOCS2)-dependent inhibition of NF-kβ (). Conversely, activation
  of S1P receptor signaling promotes a pro-inflammatory (A1) phenotype in reactive
  astrocytes (; ; ). STAT3 signaling can drive astrocytes to adopt either pro- or
  anti-inflammatory phenotypes in a highly context-specific manner (). A1 astrocytes
  are characterized by a pro-inflammatory, neurotoxic phenotype, whereas A2 astrocytes
  are anti-inflammatory, neuroprotective and promote tissue repair ().
papertitle: 'Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The
  Quest for Striking the Right Balance.'
reftext: Dana Mitchell, et al. Front Cell Neurosci. 2021;15:716947.
year: '2021'
doi: 10.3389/fncel.2021.716947
journal_title: Frontiers in Cellular Neuroscience
journal_nlm_ta: Front Cell Neurosci
publisher_name: Frontiers Media S.A.
keywords: brain tumor | glioma | neuroinflammation | multiple sclerosis | glioblastoma
  | immunotherapy | immune privileged | autoimmune
automl_pathway: 0.9413647
figid_alias: PMC8414998__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8414998__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8414998__fncel-15-716947-g002.html
  '@type': Dataset
  description: Astrocyte and Microglial Polarization. (A) Microglial Polarization.
    Microglial M1 polarization is thought to be driven predominantly by signal transducer
    and activator of transcription (STAT) 1/3/5 signaling and interferon regulatory
    factors 5 (IRF-5) and 8 (IRF-8) (; ). These M1-activated cells produce pro-inflammatory
    cytokines (e.g., TNF-α, IL-1β, IL-6, IFNy, and IL-23) and are characterized by
    increased antigen presenting activity secondary to increased expression of MHC-II
    and co-stimulatory (CD80 and CD86) molecules (; ). Conversely, M2 polarization
    depends on STAT3/6 signaling, peroxisome proliferator-activated receptor gamma
    (PPARγ)-mediated nuclear factor kappa B (NF-kβ) suppression, CREB-C/EBPβ and interferon
    regulatory factor 4 (IRF4) (). Cells exhibiting this phenotype promote tissue
    repair through the suppression of neurotoxic inflammation as well as through stimulating
    angiogenesis and tissue remodeling (). (B) Astrocyte Polarization. Signaling pathways
    implicated in regulating astroglial activation and determining phenotype, include
    the NF-kβ, sphingosine 1-phosphate (S1P) receptor, JAK/STAT and type 1 interferon
    (IFN-I) pathways (). Several factors promote activation of NF-kβ signaling in
    reactive astrocytes, including glycolipid lactosylceramide (LacCer), type I interferons,
    TGF-α and VEGF-β (). Activation of NF-kβ by these factors stimulates astrocytes
    to adopt a pro-inflammatory (A1) (). Similarly, estrogen signaling through estrogen
    receptor alpha (ERα) suppresses NF-kβ signaling and inhibits astrocytes from adopting
    a pro-inflammatory phenotype (; ). Astrocytic IFNy signaling also acts to suppress
    CNS inflammation through negative regulation of NF-kβ (). Activation of the IFNy
    pathway upregulates astrocyte expression of the aryl hydrocarbon receptor (AhR),
    which suppresses inflammation via suppressor of cytokine signaling 2 (SOCS2)-dependent
    inhibition of NF-kβ (). Conversely, activation of S1P receptor signaling promotes
    a pro-inflammatory (A1) phenotype in reactive astrocytes (; ; ). STAT3 signaling
    can drive astrocytes to adopt either pro- or anti-inflammatory phenotypes in a
    highly context-specific manner (). A1 astrocytes are characterized by a pro-inflammatory,
    neurotoxic phenotype, whereas A2 astrocytes are anti-inflammatory, neuroprotective
    and promote tissue repair ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Csf2
  - Il6
  - Il17a
  - Tnf
  - Ifng
  - Il2
  - Vegfb
  - Vegfa
  - Irf5
  - Stat1
  - Tgfa
  - Stat5a
  - Stat3
  - Irf8
  - Mbtps1
  - Nfkb1
  - Rela
  - Creb1
  - Irf4
  - Ahr
  - Stat6
  - Esr1
  - Il4
  - Il13
  - Il10
  - Tgfb1
  - Csf1
  - CSF2
  - IL6
  - IL17A
  - TNF
  - ADRA1D
  - IFNG
  - IL2
  - VEGFB
  - VEGFA
  - VEGFC
  - VEGFD
  - PGF
  - IRF5
  - STAT1
  - TGFA
  - IFNA1
  - STAT5A
  - STAT5B
  - STAT3
  - IRF8
  - MBTPS1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - IRF4
  - AHR
  - STAT6
  - ESR1
  - ERAL1
  - IL4
  - IL13
  - IL10
  - TGFB1
  - TGFB2
  - TGFB3
  - CSF1
  - GPR162
  - Ugt2b5
  - S1pr1
  - Eral1
  - Ltbp1
  - Gpr162
---
